UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Find out Where To Position Dividend Aristocrats Etf In Portfolio to optimize diversification, risk, and income potential within a blended strategy.
18,597 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Ford’s stock price down over the past five years has mirrored a broader pivot in the auto sector—from red‑hot EV bets...
Turning 55 can spark worries about retirement savings. This guide shows you practical steps to catch up, with real-wo...
A rumored $111 billion Paramount Warner Bros' deal could fuse studios, streaming, and networks under a private group,...
The Federal Reserve just paused rates, signaling a hold as markets weigh the impact on Social Security income and ret...
Inflation stretches budgets and Social Security benefits, even with a potential bigger 2027 social security. This gui...
Hershey and Vertex defy a technical warning flag as analysts stay bullish and big funds keep buying, highlighting a s...
The era of persistently higher rates is reshaping life insurers' economics. MetLife and Prudential stand to benefit a...
A high-profile stance can carry a price in Hollywood. This article explains the financial lessons from Susan Sarandon...
Oxford Square Capital trades at a 24% yield, yet a steep NAV decline and Q4 losses cast doubt on earnings durability....
Four mega-cap stocks are emerging as the most-watched potential split candidates after notable 2026 moves. ASML, GE V...
A top cloud platform just posted a record-breaking quarter as Micron pulls back, prompting investors to shift toward ...